Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.
Location: United States, Minnesota, Saint Paul
Employees: 11-50
Total raised: $31M
Founded date: 2010
Investors 3
| Date | Name | Website |
| - | Gravity Fu... | gravityfun... |
| - | BioStar Ca... | biostar.ca... |
| - | Catalyst H... | chv.vc |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 26.02.2020 | Series B | $31M | - | medcitynew... |
Mentions in press and media 8
| Date | Title | Description | Source |
| 20.07.2022 | Aria CV raises $13 million bridge round to further develop h... | - | bizjournal... |
| 11.08.2021 | Meet Josh Phillips and Darshana Zaveri, managing partners at... | CHV invests exclusively in seed, Series A and Series B companies in the medtech space Venture capit... | vator.tv/n... |
| 27.02.2020 | Malaysia’s Xeraya Capital leads $31m Series B round for US m... | Premium Malaysian private equity firm Xeraya Capital has led the $31-million Series B round of fina... | dealstreet... |
| 26.02.2020 | Aria CV nets $31M to support first US clinical study of its ... | “This will be the first implant for the treatment of pulmonary arterial hypertension,” said Gladney,... | medcitynew... |
| 25.02.2020 | Aria CV Raises $31M in Series B Funding | Aria CV, Inc., a St. Paul, Minn.-based developer of medical devices treating Pulmonary Arterial Hype... | finsmes.co... |
| 25.02.2020 | Aria CV Receives $31M Series B Funding | ST. PAUL, MN, Aria CV today announced that it has completed a $31 million Series B round of financ... | vcnewsdail... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis Healthtech is a big and broad space, so... | vator.tv/n... |
| - | Aria CV nets $31M to support first US clinical study of its ... | Aria CV has landed $31 million in Series B funding that will support the first clinical study in the... | medcitynew... |